Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.
about
TRAIL/TRAIL receptor system and susceptibility to multiple sclerosisEffects of IFN-B on TRAIL and Decoy Receptor Expression in Different Immune Cell Populations from MS Patients with Distinct Disease Subtypes.Candidate gene study of TRAIL and TRAIL receptors: association with response to interferon beta therapy in multiple sclerosis patients.TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic responseThe role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes.
P2860
Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@en
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@nl
type
label
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@en
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@nl
prefLabel
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@en
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@nl
P2093
P2860
P1476
Upregulation of TRAIL expressi ...... n beta and glatiramer acetate.
@en
P2093
P2860
P304
P356
10.1191/1352458505MS1222OA
P577
2005-12-01T00:00:00Z